Jonathan graduated with a degree in Business Studies from Stirling University in 1988 and gained an MBA from Warwick University in 1993. Since 1993 Jonathan has worked in the field of corporate finance in the EU, including four years working on the creation and launch of the pan-European stock market, EASDAQ, which was subsequently taken over by NASDAQ.

 In 1997, Jonathan joined the corporate finance department of Beeson Gregory Limited and was appointed as a director in 1998. He joined Gambit Corporate Finance as a partner in 2002 where he continued to provide corporate finance and advisory services, which he left in October 2003.

 Jonathan is currently a director of Creon Corporation Plc, Cobra Capital Limited, Syndicate Asset Management Plc, Equity Pre-IPO Investments Ltd and Futura Medical Plc, all of which are traded on AIM.

 Jonathan has acted as the lead adviser in a wide variety of transactions for both private and public companies in the EU and UK. This has included raising funds, mergers, acquisitions and disposals and corporate restructuring.